Involvement of autophagy in mesaconitine-induced neurotoxicity in HT22 cells revealed through integrated transcriptomic, proteomic, and m6A epitranscriptomic profiling

Front Pharmacol. 2024 Jun 13:15:1393717. doi: 10.3389/fphar.2024.1393717. eCollection 2024.

Abstract

Background: Mesaconitine (MA), a diester-diterpenoid alkaloid extracted from the medicinal herb Aconitum carmichaelii, is commonly used to treat various diseases. Previous studies have indicated the potent toxicity of aconitum despite its pharmacological activities, with limited understanding of its effects on the nervous system and the underlying mechanisms. Methods: HT22 cells and zebrafish were used to investigate the neurotoxic effects of MA both in vitro and in vivo, employing multi-omics techniques to explore the potential mechanisms of toxicity. Results: Our results demonstrated that treatment with MA induces neurotoxicity in zebrafish and HT22 cells. Subsequent analysis revealed that MA induced oxidative stress, as well as structural and functional damage to mitochondria in HT22 cells, accompanied by an upregulation of mRNA and protein expression related to autophagic and lysosomal pathways. Furthermore, methylated RNA immunoprecipitation sequencing (MeRIP-seq) showed a correlation between the expression of autophagy-related genes and N6-methyladenosine (m6A) modification following MA treatment. In addition, we identified METTL14 as a potential regulator of m6A methylation in HT22 cells after exposure to MA. Conclusion: Our study has contributed to a thorough mechanistic elucidation of the neurotoxic effects caused by MA, and has provided valuable insights for optimizing the rational utilization of traditional Chinese medicine formulations containing aconitum in clinical practice.

Keywords: N6-methyladenosine modification; autophagy; mesaconitine; neurotoxicity; proteomic.

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was funded by the National Natural Science Foundation of China (82104520 and 82174068), the Natural Science Foundation of Fujian Province (2021J05045), the Fujian Medical University High-level Talent Research Startup Funding Project (XRCZX2023003 and XRCZX2020014), the Open Research Fund of Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), the Ministry of Education (FMUGIC-202101), the Startup Fund for Scientific Research of Fujian Medical University (2021QH1004), and Fujian Research and Training Grants for Young and Middle-aged Leaders in Healthcare.